Skip to content
Disclosery

EXANE DERIVATIVES: M position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on M, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 707 M shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 707 shares
    Change vs previous 13F -1,400 shares

    0.01% of the 13F portfolio, value $12,950.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,107 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $51,325.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,107 shares
    Change vs previous 13F +1,347 shares

    0.01% of the 13F portfolio, value $55,161.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 760 shares
    Change vs previous 13F -10,495 shares

    <0.01% of the 13F portfolio, value $17,176.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 11,255 shares
    Change vs previous 13F -8,608 shares

    0.05% of the 13F portfolio, value $208,779.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 19,863 shares
    Change vs previous 13F -15,856 shares

    0.1% of the 13F portfolio, value $321,578.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 35,719 shares
    Change vs previous 13F -29,441 shares

    0.12% of the 13F portfolio, value $401,833.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 65,160 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $371,402.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).